<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>capecitabine</title><link>http://www.unboundmedicine.com/medline/ebm/research/capecitabine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Management of advanced breast cancer with the epothilone B analog, ixabepilone.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920932/full_citation/Management_of_advanced_breast_cancer_with_the_epothilone_B_analog_ixabepilone_</link><description>Gradishar W <br/><span class="title">Management of advanced breast cancer with the epothilone B analog, ixabepilone. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug design, development and therapy">Drug Des Devel Ther 2009.:163-171.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920932/abstract/Management_of_advanced_breast_cancer_with_the_epothilone_B_analog_ixabepilone_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920932/full_citation/Management_of_advanced_breast_cancer_with_the_epothilone_B_analog_ixabepilone_">Full Citation</a></description></item><item><title>Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920832/full_citation/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_</link><description>Conroy T, Hebbar M, Bennouna J, et al. <br/><span class="title">Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of cancer">Br J Cancer 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920832/abstract/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920832/full_citation/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_">Full Citation</a></description></item><item><title>Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917849/full_citation/Effectiveness_of_a_Home_Care_Nursing_Program_in_the_Symptom_Management_of_Patients_With_Colorectal_and_Breast_Cancer_Receiving_Oral_Chemotherapy:_A_Randomized_Controlled_Trial_</link><description>Molassiotis A, Brearley S, Saunders M, et al. <br/><span class="title">Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917849/abstract/Effectiveness_of_a_Home_Care_Nursing_Program_in_the_Symptom_Management_of_Patients_With_Colorectal_and_Breast_Cancer_Receiving_Oral_Chemotherapy:_A_Randomized_Controlled_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917849/full_citation/Effectiveness_of_a_Home_Care_Nursing_Program_in_the_Symptom_Management_of_Patients_With_Colorectal_and_Breast_Cancer_Receiving_Oral_Chemotherapy:_A_Randomized_Controlled_Trial_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19917849">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917849/Effectiveness_of_a_Home_Care_Nursing_Program_in_the_Symptom_Management_of_Patients_With_Colorectal_and_Breast_Cancer_Receiving_Oral_Chemotherapy:_A_Randomized_Controlled_Trial_">Find Related Articles</a> </description></item><item><title>Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917541/full_citation/Sensory_motor_axonal_peripheral_neuropathy_in_an_advanced_breast_cancer_patient_treated_with_ixabepilone_</link><description>Bosch-Barrera J, Espinós J, Gómez-Ibáñez A, et al. <br/><span class="title">Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone. [Journal Article]</span><br/><span class="source" title="Clinical &amp; translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico">Clin Transl Oncol 2009 Nov; 11(11):765-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917541/abstract/Sensory_motor_axonal_peripheral_neuropathy_in_an_advanced_breast_cancer_patient_treated_with_ixabepilone_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917541/full_citation/Sensory_motor_axonal_peripheral_neuropathy_in_an_advanced_breast_cancer_patient_treated_with_ixabepilone_">Full Citation</a></description></item><item><title>Gemcitabine for the treatment of metastatic breast cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19804683/full_citation/Gemcitabine_for_the_treatment_of_metastatic_breast_cancer_</link><description>Jones J, Takeda A, Tan SC, et al. <br/><span class="title">Gemcitabine for the treatment of metastatic breast cancer. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Health technology assessment (Winchester, England)">Health Technol Assess 2009 Sep.:1-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19804683/abstract/Gemcitabine_for_the_treatment_of_metastatic_breast_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19804683/full_citation/Gemcitabine_for_the_treatment_of_metastatic_breast_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19804683/Gemcitabine_for_the_treatment_of_metastatic_breast_cancer_">Find Related Articles</a> </description></item><item><title>Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906761/full_citation/Randomized_phase_III_trial_comparing_docetaxel_plus_epirubicin_versus_docetaxel_plus_capecitabine_as_first_line_treatment_in_women_with_advanced_breast_cancer_</link><description>Mavroudis D, Papakotoulas P, Ardavanis A, et al. <br/><span class="title">Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906761/abstract/Randomized_phase_III_trial_comparing_docetaxel_plus_epirubicin_versus_docetaxel_plus_capecitabine_as_first_line_treatment_in_women_with_advanced_breast_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906761/full_citation/Randomized_phase_III_trial_comparing_docetaxel_plus_epirubicin_versus_docetaxel_plus_capecitabine_as_first_line_treatment_in_women_with_advanced_breast_cancer_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19906761">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906761/Randomized_phase_III_trial_comparing_docetaxel_plus_epirubicin_versus_docetaxel_plus_capecitabine_as_first_line_treatment_in_women_with_advanced_breast_cancer_">Find Related Articles</a> </description></item><item><title>Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906561/full_citation/Adjuvant_capecitabine_in_combination_with_docetaxel_and_cyclophosphamide_plus_epirubicin_for_breast_cancer:_an_open_label_randomised_controlled_trial_</link><description>Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, et al. <br/><span class="title">Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="The lancet oncology">Lancet Oncol 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906561/abstract/Adjuvant_capecitabine_in_combination_with_docetaxel_and_cyclophosphamide_plus_epirubicin_for_breast_cancer:_an_open_label_randomised_controlled_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906561/full_citation/Adjuvant_capecitabine_in_combination_with_docetaxel_and_cyclophosphamide_plus_epirubicin_for_breast_cancer:_an_open_label_randomised_controlled_trial_">Full Citation</a></description></item><item><title>Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19904537/full_citation/Preclinical_study_of_prolonged_administration_of_trastuzumab_as_combination_therapy_after_disease_progression_during_trastuzumab_monotherapy_</link><description>Fujimoto-Ouchi K, Sekiguchi F, Yamamoto K, et al. <br/><span class="title">Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19904537/abstract/Preclinical_study_of_prolonged_administration_of_trastuzumab_as_combination_therapy_after_disease_progression_during_trastuzumab_monotherapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19904537/full_citation/Preclinical_study_of_prolonged_administration_of_trastuzumab_as_combination_therapy_after_disease_progression_during_trastuzumab_monotherapy_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19904537/Preclinical_study_of_prolonged_administration_of_trastuzumab_as_combination_therapy_after_disease_progression_during_trastuzumab_monotherapy_">Find Related Articles</a> </description></item><item><title>Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19903796/full_citation/Bevacizumab_plus_capecitabine_as_a_salvage_therapy_in_advanced_adrenocortical_carcinoma_</link><description>Wortmann S, Quinkler M, Ritter C, et al. <br/><span class="title">Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of endocrinology / European Federation of Endocrine Societies">Eur J Endocrinol 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19903796/abstract/Bevacizumab_plus_capecitabine_as_a_salvage_therapy_in_advanced_adrenocortical_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19903796/full_citation/Bevacizumab_plus_capecitabine_as_a_salvage_therapy_in_advanced_adrenocortical_carcinoma_">Full Citation</a></description></item><item><title>Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19901111/full_citation/Neoadjuvant_Chemotherapy_Shows_Similar_Response_in_Patients_With_Inflammatory_or_Locally_Advanced_Breast_Cancer_When_Compared_With_Operable_Breast_Cancer:_A_Secondary_Analysis_of_the_GeparTrio_Trial_Data_</link><description>Costa SD, Loibl S, Kaufmann M, et al. <br/><span class="title">Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19901111/abstract/Neoadjuvant_Chemotherapy_Shows_Similar_Response_in_Patients_With_Inflammatory_or_Locally_Advanced_Breast_Cancer_When_Compared_With_Operable_Breast_Cancer:_A_Secondary_Analysis_of_the_GeparTrio_Trial_Data_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19901111/full_citation/Neoadjuvant_Chemotherapy_Shows_Similar_Response_in_Patients_With_Inflammatory_or_Locally_Advanced_Breast_Cancer_When_Compared_With_Operable_Breast_Cancer:_A_Secondary_Analysis_of_the_GeparTrio_Trial_Data_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19901111">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19901111/Neoadjuvant_Chemotherapy_Shows_Similar_Response_in_Patients_With_Inflammatory_or_Locally_Advanced_Breast_Cancer_When_Compared_With_Operable_Breast_Cancer:_A_Secondary_Analysis_of_the_GeparTrio_Trial_Data_">Find Related Articles</a> </description></item></channel></rss>